Peptide-Modified Nanoparticles for Tumor Targeting and Molecular Imaging

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Nanoparticles are effective for co-delivering therapeutics and imaging agents for tumor targeting.
• Active targeting using ligands against tumor-specific moieties enhances nanoparticle efficacy.
• Peptides are ideal for nanoparticle modification due to their small size, ease of synthesis, and low immunogenicity.

Purpose of the Study:

• To review peptide-modified nanoparticles for tumor targeting therapy and molecular imaging.
• To classify these nanoparticles based on their peptide-targeting ligands.
• To discuss the development of targeting peptides and nanoparticles.

Main Methods:

• Literature review of peptide-modified nanoparticles in cancer research.
• Classification of nanoparticles based on peptide-targeting ligand strategies.
• Analysis of current trends and future directions in peptide-nanoparticle development.

Main Results:

• Peptide-modified nanoparticles demonstrate significant potential in active tumor targeting.
• These systems enable simultaneous therapeutic delivery and molecular imaging.
• Various peptide-targeting ligands have been identified for different tumor types.

Conclusions:

• Peptide-modified nanoparticles represent a versatile platform for advanced cancer diagnostics and therapeutics.
• Further development in targeting peptide design and nanoparticle engineering will improve clinical translation.
• This approach holds promise for personalized cancer medicine and enhanced patient outcomes.